![Cameron McDonough](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cameron McDonough
Director/Board Member at
THIRD HARMONIC BIO, INC.
Profile
Cameron Geoffrey McDonough is the founder of Catalyst Medical Solutions, Inc. Dr. McDonough is Chief Executive Officer & Director at NodThera Ltd. since 2026.
Dr. McDonough is Independent Director at Third Harmonic Bio, Inc. since 2024.
Dr. McDonough is Advisor at Atlas Venture Advisors, Inc. Dr. McDonough was President & Chief Executive Officer at Swedish Orphan Biovitrum AB from 2011 to 2017.
Dr. McDonough was Independent Director at PTC Therapeutics, Inc. from 2013 to 2017.
Dr. McDonough was Independent Director at Zafgen, Inc. from 2015 to 2020.
Dr. McDonough was Independent Director at Generation Bio Co. from 2025 to 2026.
Dr. McDonough was Independent Non-Executive Director at Surface Oncology, Inc. from 2018 to 2022.
Dr. McDonough was President-Europe, Middle East & Africa Region at Genzyme Corp.
from 2002 to 2011.
Dr. McDonough completed undergraduate studies at The University of North Carolina at Chapel Hill.
Dr. McDonough completed graduate studies at Harvard Medical School in 1997.
Cameron McDonough active positions
| Companies | Position | Start |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Director/Board Member | 2024-03-27 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Chief Executive Officer | 2026-02-03 |
Former positions of Cameron McDonough
| Companies | Position | End |
|---|---|---|
| GENERATION BIO CO. | Chief Executive Officer | 2025-10-30 |
| SURFACE ONCOLOGY, INC. | Director/Board Member | 2022-02-27 |
| LARIMAR THERAPEUTICS, INC. | Director/Board Member | 2020-04-30 |
| PTC THERAPEUTICS, INC. | Director/Board Member | 2017-09-17 |
| SWEDISH ORPHAN BIOVITRUM AB | Chief Executive Officer | 2017-05-21 |
Training of Cameron McDonough
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Catalyst Medical Solutions, Inc. | |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
- Stock Market
- Insiders
- Cameron McDonough
Choose MarketScreener 
